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Abstract.  We have previously shown that an active 
epidermal growth factor receptor (EGF-R) kinase is 
necessary for efficient sorting of the EGF-R to the ly- 
sosome, and we have shown that this occurs in the 
multivesicular body (MVB), where EGF-R are sorted 
away from recycling receptors by being removed to the 
internal vesicles of the MVB. The aim of the present 
study was to identify substrates of the EGF-R kinase 
associated with MVBs which might play a role in this 
sorting process. We used a density shift technique to 
isolate MVBs and show that the major substrates pbos- 
phorylated in vitro within MVBs which contain an ac- 
tive EGF-R kinase are the EGF-R itself and annexin I. 
Annexin I is associated with both plasma membrane 
and MVBs in a calcium-independent manner but can 
be phosphorylated in vitro only in MVBs. Phosphor- 
ylation of calcium-independent annexin I in isolated 
MVBs converts it to a form that requires calcium for 
membrane association.  In cells with an active EGF-R 
kinase the amount of calcium-independent annexin I in 
MVBs is reduced,  suggesting that a phosphorylation- 
induced conversion of the calcium independent to the 
calcium-dependent form also occurs in vivo. Our ob- 
servations, together with the known properties of an- 
nexin I in mediating membrane fusion, suggest that in- 
ward vesiculation in MVBs is induced by the EGF-R 
and is mediated by phosphorylated annexin I. 
W 
'H~N EGF binds to its receptor the intrinsic  tyro- 
sine kinase of the receptor is activated,  resulting in 
phosphorylation of the receptor itself and various 
other proteins (Ushiro and Cohen, 1980). During this time 
the EGF-EGF-receptor (EGF-R)  1 complex is rapidly inter- 
nalized and processed within the endocytic pathway where 
it becomes degraded (Carpenter and Cohen,  1976). A mu- 
tant EGF-R lacking  an active kinase is internalized  in re- 
sponse to EGF at the same rate as the wild type EGF-R but 
the kinase-negative  EGF-R is not efficiently degraded and a 
significant  proportion of the mutant EGF-R recycle to the 
ceil surface (Honegger et al., 1987; Felder et al., 1990). By 
EM we have shown that saturating  concentrations  of EGF 
stimulate internalization  of both wild type and kinase nega- 
tive EGF-R to multivesicular bodies but within this compart- 
ment they have distinctly  different  distributions  (Felder et 
al., 1990). Since only wild type EGF-R are efficiently trans- 
ferred to the internal  vesicles of the multivesicular  body 
(MVB) we have proposed that removal of EGF-R from the 
perimeter membrane of the endocytic pathway allows them 
to be degraded. 
While it is possible that the activated EGF-R kinase initi- 
ates a series of events in the plasma membrane which results 
in sorting at the level of the MVB it is also possible that the 
1. AbbreviaU'ons used in this paper. EGF-R, epidermal growth factor recep- 
tor; MVB, multivesicular body. 
EGF-R kinase is active in the endosome where it triggers the 
events that lead to its degradation.  The aim of the present 
study was to determine whether there are substrates  of the 
EGF-R kinase specifically associated with MVBs. We have 
adapted a previously described density shift protocol (Futter 
and Hopkins,  1989) to isolate highly  purified  MVBs con- 
raisins  EGF-R and show that the major substrates  of the 
EGF-R kinase in MVBs are the EGF-R itself and annexin I. 
Since annexin I is a protein which interacts with membranes 
and actin-containing  cytoskeletal elements  (Glenney et al., 
1987) and can promote phospholipid vesicle fusion in vitro 
(Ernst et al., 1990), it could regulate the production of inter- 
nal vesicles within MVBs. 
Materials and Methods 
Cell Lines 
NIH 3T3 ceUs, strain 2.2, transfected with plasmid bearing either the full- 
length cDNA for the human EGF-R (HER14 ceils), or the cDNA encoding 
the human EGF-R with lysine 721 replaced with alRnin~ (K721A ceils), and 
each etpressin8 roughly  400000 receptors per cell, were  used (Honegger 
et al., 1987). Cells  were  maintained in DME supplemented  with 10% FCS 
at 37~  in a 5  % CO2 atmosphere. 
Colloidal Gold Complexes 
Gold particles (10 nm) were prepared using the tannic acid method of Slot 
and Geuze,  (1985), and were stabilized with the mAb 108, according to 
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azide at 4~  and were washed by centrifugation in an airfuge (Beckman 
Instrmnents, Palo Alto, CA) at 150,000 g for 5 rain immediately before use. 
Iodination 
EGF (mouse EGF; Sigma Chemical Co., Peele, UK) was iodinated accord- 
ing to the method of Hunter and Greenwood (1962) and protein A was iodi- 
hated using  iodobeads  (Pierce,  Chester,  UK). 
Incubation Procedures 
All incubations were performed in DME containing 20 mM Hepes, pH 7.4, 
2 mg/mi BSA. EGF was used at a concentration of 20 nM. 108-gold was 
used at a concentration that gave ODss0 of 0.3-0.4. Incubations were per- 
formed at 37~  unless otherwise indicated and for the times indicated in 
Results. Where the proportion of cell-associated  nSI-EGF that was plasma 
membrane bound was to be determined, cells were incubated in acetic acid- 
saline, pH 2.5, for 5 min at 4~  to remove plasma membrane-bound EGF, 
before digestion of the cells in 5 M NaOH. 
SubceUular Fractionation Procedure 
Cells were washed three times at 4~  with lysis buffer (10 mM ttiethanola- 
mine, pH 7.4, 0.25 M sucrose,  1 mM EDTA, 200 #M orthovanadate,  1 mM 
PMSF). Cells were scraped off the dish in the minimum volume of lysis 
buffer and lysed by eight strokes through a 21 g needle. Unbroken cells and 
nucleii were removed  by centrifugation  at 800 g for 5 min at 4~  The result- 
ing postnuclear supernatant was layered onto a 12 mi 26-52 % sucrose gra- 
dient, containing triethanolamine, EDTA, orthovanadate,  and PMSF at the 
same concentrations and pH as the lysis buffer. Gradients were then cen- 
trifllged ill a Beckman SW40 rotor at 200,000 g for 15 h at 4~  in a Beckman 
L70 ultracentrifuge.  Gradients were fraetionated from the bottom into 15 
x  0.9-ml fractions. 
EM 
Cells and fractions were fixed in dilute Karnovsky fixative, postfixed in os- 
mium tetroxide,  and embedded and sectioned so that the full thickness of 
the pellet could be examined.  Sections were stained in aqueous uranyl ace- 
tat~ and lead citrate and examined in a CM12 Philips electron microscope. 
SDS-PAGE and Western Blotting 
SDS-PAGE  was  performed  under  reducing  conditions.  Proteins  on 
SDS-polacrylamide gels were eleetrophoretically transferred to nitrocellu- 
lose for 16 h in a transfer apparatus (Bio-Rad  Laboratories, Cambridge, 
MA) at a constant current of 100 mA. After incubation with either rabbit 
anti-EGF-R antiserum, RK2 (Kris et al.,  1985), rabbit anti-phosphotyro- 
sine antiserum, or rabbit anti-aunexJn I antiserum (a gift from S. Moss, 
University College,  London), blots were washed and incubated in 125I- 
protein A. Blots were analyzed by autoradiography and, where quanfitation 
was performed, radioactive bands were excised,  and counted. 
In Vitro Phosphorylation Studies 
Cell fractions were resuspended in 20 mM Hepes, pH 7.4, 150 mM NaCI. 
Fractions were incubated for 15 min at 4~  in the presence of 5  mM 
MnCI2, 20 ~M orthova~d~_te, and [.y-nP]ATP (5 ~M). Reactions were 
stopped by the addition of 10% TCA, aud "[CA precipitates were examined 
by SDS-PAGE. 
To examine the effects of phosphorylation on calcium dependence of 
membrane association of MVB proteins, phosphorylation reactions were 
performed as above. MVBs were then washed twice with 20 mM Hepes, 
pH 7.4,  150 mM NaCl, 200/tM orthovanadate,  containing either 1.5 mM 
EDTA or 1.5 mM CaCl2, by centrifugation in a Beclmmn TLI00.4 rotor at 
200,000 g for I h at 40C in a Beckman TLX ullracentrifilgc,  and the pellets 
were e~amined by SDS-PAGE. 
Annexin I Immunoprecipitation 
To identify aune~fin I, in vitro pbosphorylation assays were carried out as 
above, but were stopped by the addition of NDET (10 m_M Tris, pH 7.4, 
1% NP-40, 0.4%  deoxycholate,  66 mM EI)I'A), containing 1 mM PMSF, 
200/tM orthovanadate  and 0.2 % SDS. Samples were clarified by centrifuga- 
tion (14,000 g for 5 rain), and were then incubated with a rabbit polyclonal 
antibody against annexin I. Antibody-bound  proteins were immunoprecipi- 
rated usLng Staphylococcus  aureus, and the washed immunoprecipitate was 
analyzed by SDS-PAGE. 
Results 
Isolation of  Highly Purifw.d 
Endosomes by Density-shift  Using EGF-R 
Antibody-Gold  Complexes 
We have previously shown in H.Ep.2 cells that antibody to 
the transferrin  receptor complexed to colloidal gold can be 
used to modify the density of endocytic compartments in- 
volved in the processing of the EGF-receptor complex, so 
that they can be purified  by sucrose density centrifugation 
(Futter and Hopkins,  1989).  In the present study we ex- 
tended this technique to NIH-3T3 ceils transfected  with ei- 
ther the wild type human EGF receptor or a human EGF 
receptor with a point mutation in the putative ATP binding 
site, rendering the receptor kinase negative (Honegger et al., 
1987). To isolate endocytic compartments contai~in~ EGF-R 
by density shift we employed a mAb (108) to EGF-R com- 
plexed to colloidal gold.  The  108  antibody binds to the 
external  domain of the EGF-R and has been shown,  when 
saturating EGF concentrations  are used, not to stimulate in- 
ternalization  or kinase activity of the EGF-R, or to interfere 
with EGF binding (Bellot et al., 1990). To induce a sufficient 
increase in density of endocytic compartments containing 
108-gold, it was necessary to stimulate cells with saturating 
concentrations  of EGE Under these conditions  both the ki- 
nase positive and negative EGF-R are internalized  at similar 
rates (Felder et al., 1990). Our previous studies using gold 
complexes to density shift endocytic compartments showed 
that gold-loaded endosomes will pellet through 52 % sucrose 
whereas gold-loaded plasma membranes will not (Futter and 
Hopkins, 1989). To begin we established the rate of EGF-R 
internalization  by following  nq-EGF uptake,  and showed 
that >70% was internalized  within 20 rain of EGF stimula- 
tion (Fig.  1 a). 
Fig. 1 b shows the recovery of EGF and EGF-R in the pel- 
let after sucrose density gradient fractionation  of cells after 
similar stimulation  with EGF. Recovery of EGF-R was as- 
sessed by Western blotting  with anti-EGF-R antibody.  The 
increase in recovery of EGF and EGF-R in the pellet with 
increasing  lengths  of  incubation  after  EGF  stimulation 
showed similar kinetics to that of EGF-stimulated internali- 
zation,  showing  that endocytic compartments  rather  than 
plasma membrane pellet under the fractionation  conditions 
used. 
Examination  of the endosome pellet isolated by fraction- 
ation  of  108-gold-loaded  cells  expressing  the  wild type 
EGF-R 20 rain after EGF stimulation  showed that all mem- 
branous elements labeled with gold were endosomal, many 
of which were clearly identifiable as MVBs (Fig. 2 a). Quan- 
titation of the number of vesicles which contained gold by 
counting  random  sections  showed  that  34%  of vesicle 
profiles  found in the pellet contained gold. Vesicle profiles 
which lacked gold presumably contained gold particles in 
another section plane. Electron microscopic examination of 
the pellet from cells expressing  the kinase negative EGF-R 
showed that 14% of the vesicle profiles contained gold. This 
lower figure compared to the wild type fraction is consistent 
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Rgure 1. (a) Cells expressing wild type EGF-R were stimulated 
with 125I-EGF for the indicated times. The percent of total cell- 
associated EGF that had been internalized was determined by acid 
stripping. (b) Cells expressing wild type EGF-R were incubated 
with 108-gold for 30 rain and were then stimulated with nSI-EGF 
for the indicated times. Cells were lysed and fractionated. The per- 
cent of posmuclear supernatant ~2SI-EGF (~) and EGF-R (,,) that 
was recovered in the pellet after sucrose density gradient fractiona- 
tion was determined. Quantitation of  the EGF-R was performed by 
blotting gradient fractions with anti-EGF-R antibody. Iodinated 
protein A and autoradiography were used to visualize  bands, which 
were excised and counted. 
with observations on intact cells (Felder et al., 1990) which 
have shown that there is significantly  less EGF-R in the MVB 
compartment of kinase negative cells.  It should be noted 
nevertheless that the majority of  gold-loaded elements in the 
pellets from the kinase negative cells are M31Bs (Fig. 2 b). 
Presumably the other gold-containing elements of the endo- 
cytic pathway were too buoyant to pellet. Previous studies 
have shown, through measurement of  marker enzyme activi- 
ties and try EM, that in a number of  different  cell lines nonen- 
dosomal organelles do not pellet under the fractionation con- 
ditions used (Beardmore et al.,  1988;  Futter et al.,  1989; 
Beaumelle and Hopkins, 1990).  However amorphous mate- 
Hgure 2. Cells expressing either wild type (a) or klna~ negative 
(b) EGF-R were incubated with 10g-gold  for 30 rain, and were then 
stimulated with EGF for 20 rain. Cells were then lysed and frac- 
tionated, and the pellet after sucrose gradient fractionation was 
processed for microscopy. All membranous elements that contain 
gold are endosomal, many of which are MVBs. Amorphous mate- 
rial, presumably of cytoskeletal nature, consistently pellets with 
endosome fractions. Bar, 0.5/an. 
rial, presumably a component of the cytoskeleton, consis- 
tently pellets with endosome fractions. 
The Fate of  the Plasma Membrane during Density 
Shift Separation of  Gold-loaded Endosomes 
When cells were stimulated with EGF for 1 rain after pre- 
incubation with 108-gold (when the majority of EGF-R are 
plasma membrane associated), the density of the plasma 
membrane fraction was increased, Thus, in the absence of 
108-gold binding, plasma membrane was found in a peak in 
fractions 8-12  (Fig. 3 a) while binding of 108-gold  to the 
plasma membrane caused a shift to fraction 6 (Fig. 3 b). Af- 
ter stimulation of cells with EGF for one minute EGF-R was 
still found in fraction 6 (Fig. 3 c). EM of  this fraction showed 
that it was composed of large vesicle profiles bearing EGF- 
R-gold particles on their outer surfaces (results not shown), 
in contrast to MVBs where the gold particles were found 
only on the inner surfaces of the perimeter membrane. 
Substrates Phosphorylated in Endosomes and 
Plasma Membrane Isolated  from Cells Expressing 
V~ld type EGF-R Kinase 
To determine whether proteins are phosphorylated in MVBs 
as a result of activation of the EGF-R kinase, phosphoryla- 
tion was examined in endosomes isolated from NIH 3T3 
cells expressing either the wild type or the kinase negative 
EGF-R. Endosomes were isolated 20 rain after EGF stimu- 
lation when the majority of both kinase negative and wild 
type EGF-R are in MVBs (Felder et al., 1990) and the den- 
sity shifted fractions are composed primarily of  MVBs (Fig. 
2). When MVBs isolated from NIH 31"3 cells expressing the 
wild type EGF-R were incubated with [y-32p]ATP in vitro 
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Figure  3.  Cells  expressing 
wild type EGF-R were incu- 
bated with no gold (a),  108- 
gold for 30 rain (b), or 108- 
gold for 30 rain, foilowed by 
stimulation  with EGF for 1 rain 
(c). Ceils were lysed and frac- 
tionated and gradient fractions 
were analyzed  by  Western  blot- 
ting with anti-EGF-R  antibody. 
Iodinated protein A and auto- 
radiography were used to vi- 
sualize bands, which were ex- 
cised and counted. 
two  major  phosphorylated  substrates  were  detected,  the 
EGF-R itself and a protein of approximately 35 kD (Fig. 4 
a).  The 35-kD protein could be immunoprecipitated with 
anti-annexin I antibody (Fig. 4 b). 
To determine  whether  annexin  I  is  phosphorylated  in 
plasma membrane fractions in addition to MVBs, plasma 
membrane fractions were isolated from cells stimulated with 
EGF for one minute. When these fractions were incubated 
with  [y-32P]ATP in  vitro  several  substrates  were  phos- 
phoryiated including the EGF-R (Fig. 4 a), but immunopre- 
cipitation with annexin I antibody showed they did not in- 
clude annexin I (Fig. 4  b). 
MVB and plasma membrane fractions from cells express- 
ing the kinase negative EGF-R, used as a control, showed 
that neither the EGF-R nor the 35-kD protein were phos- 
phorylated (Fig. 4, a  and b). 
To confirm that the phosphorylation of annexin I  in the 
MVB was due to the presence of an active EGF-R kinase we 
carried out a parallel study using H.Ep.2 cells in which we 
have shown previously that EGF-R containing MVBs can be 
isolated by density shift when loaded with anti-transferrin 
receptor-gold complexes and stimulated with EGF (Futter 
and Hopkins,  1989).  Western blotting the isolated MVBs 
showed that EGF stimulation of transferrin receptor-gold- 
loaded cells resulted in a fivefold increase in the amount of 
EGF-R that co-localized with transferrin receptor in MVBs 
(results not shown). In vitro phosphorylation assays showed 
that a number of proteins became phosphorylated in MVBs 
isolated from H.Ep.2 cells, but only in MVBs that contained 
an active EGF-R kinase did the EGF-R and a 35-kD protein 
become phosphorylated  (Fig.  5  a).  Immunoprecipitation 
confirmed this protein was annexin I  (Fig.  5 b). 
We conclude that annexin I is present in isolated MVBs 
and that it can be phosphorylated in vitro in the presence of 
an active EGF-R kinase. 
Phosphorylation  and the Calcium 
Dependence of  Annexin I Binding to MVBs 
and Plasma Membrane 
Aunexin I  has been isolated as  an EDTA eluate of mem- 
Figure 4. NIH 3T3 ceils expressing either the wild type (+) or the 
kinase negative (-) EGF-R were incubated with 108-gold f~r 30 
rain. Cells were then stimulated with EGF for 1 rain to isolate a 
plasma membrane fraction (PM) or for 20 rain to isolate an MVB 
fraction (MVB). Ceils were then lysed and fracfionated. The PM 
fraction was taken from fraction 6 and the MVB fraction was taken 
from the peilet after sucrose gradient fractionation. In vitro phos- 
phorylation reactions were performed on the isolated fractions as 
described in Materials and Methods. Either the whole fraction (a) 
or an anti-annexin I immunoprecipitation of the fraction (b) were 
analyzed by SDS-PAGE  on a 10% gel. The EGF-R is present in anti- 
annexin I immunoprecipitations because the fractions contain anti- 
EGF-R gold, but in control immunoprecipitations that do not in- 
clude anti-annexin I antibody, annexin I is not immunoprecipitated. 
Gel loadings with respect to the EGF-R are 1:2:1:1.4 for -PM: 
+PM:  -MVB:  +MVB. 
branes and shown to associate with phospholipids in a cal- 
cium dependent manner (Glenney et al.,  1987). Haigler et 
al.,  (1987)  have  shown  that  in  addition  to  the  calcium- 
dependent  form there  is  a  form of annexin I  in  human 
placenta which associates with membranes independently of 
calcium and can be phosphorylated by the EGF-R kinase. 
Phosphorylation of this form of aunexin I converts the pro- 
rein into a form that associates with membranes only in the 
presence of calcium. The MVBs used in the present study 
arc isolated in the presence of EDTA and so the annexin I 
that is phosphorylated in vitro must remain associated with 
membranes in the absence of calcium. In order to determine 
the effect of phosphoryiation on the calcium dependence of 
annexin I in MVBs, isolated fractions were incubated with 
[y-32P]ATP and then washed two times in lysis buffer con- 
taining either 1.5 mM EDTA or 1.5 mM Ca  2+. The mem- 
brane pellet was examined by SDS-PAGE. After washing in 
EDTA phosphoryiated annexin I  was no longer associated 
with the MVB pellet. However in the presence of calcium the 
protein remained associated with MVBs (Fig. 6). 
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incubated  with  B3/25  (anti- 
transferrin  receptor)-gold  for 
60 rain  and  were  then  incu- 
bated in the presence  (+) or 
absence (-) of  EGF for  20 min 
(in the continued presence  of 
B3/25-gold).  Cells were then 
lysed and fractionated. In  vitro 
phosphorylafion  reactions were 
performed on the MVB frac- 
tions as described in Materials 
and Methods. Either the whole 
fraction (a) or an anti-annexin 
I immunoprecipitation  of the 
fraction (b) were analyzed by 
SDS-PAGE on a  10% gel. 
The Influence of  EGF-R Kinase on the 
Amount of  Annexin I Associated with Plasma 
Membrane and MVBs 
To determine whether an active EGF-R kinase is necessary 
for association of annexin I with MVBs isolated MVBs were 
Western blotted with anti-aunexin I antibody and the amount 
of annexin I  relative to EGF-R was quantitated.  Annexin I 
was present in MVB fractions from cells expressing the wild 
type EGF-R and also those expressing the kinase negative 
EGF-R.  However MVBs  from NIH 3T3  ceils  containing 
wild type EGF-R had three- to fourfold less annexin I (rela- 
tive to EGF-R) than kinase negative MVBs (Fig. 7).  Simi- 
larly annexin I was present in MVBs from H.Ep.2 cells iso- 
Figure 6.  NIH 3T3 cells  ex- 
pressing wild type EGF-R were 
incubated with 108-gold for 30 
min and were then stimulated 
with EGF for 20 rain.  Cells 
were  then  lysed  and  frac- 
tionated.  In  vitro phosphor- 
ylation  reactions  were  per- 
formed on the MVB fractions 
as described in Materials and 
Methods.  MVBs  were  then 
washed  in  the  presence  of 
EDTA (EDTA)  or calcium (Ca). 
Washed pellets were analyzed 
by SDS-PAGE on a  10% gel. 
Figure 7.  (a) NII-I 3T3 cells 
expressing  wild  type (+)  or 
kinase  negative  (-)  EGF-R 
were incubated with 108 gold 
for 30 rain.  Cells  were then 
stimulated with EGF for 1 rain 
and a plasma membrane frac- 
.....  tion  isolated  (PM) or for 20 
rain and an MVB fraction iso- 
lated (MVB). Fractions were Western blotted with anti-EGF-R an- 
tibody  and  anti-annexin-I  antibody. Iodinated  protein  A  and 
autoradiography were used to visualize bands, which were excised 
and counted.  The amount of aunexin I (relative to the EGF-R) in 
fractions from wild type cells is expressed as a % of  that in the cor- 
responding fractions from kinase negative cells. Results are mean 
+  SEM of four observations. 
lated using transferrin receptor gold with or without prior 
EGF stimulation, but MVBs containing an active EGF-R ki- 
nase contained approximately twofold less annexin I  (rela- 
tive to transferrin receptor) than MVBs lacking an active 
EGF-R kinase (results not shown).  We conclude therefore 
that an active EGF-R kinase is not necessary for association 
of annexin I  with MVBs.  In addition,  the reduction in the 
amount of calcium-independent annexin I in MVBs contain- 
ing an active EGF-R kinase is consistent with the phospbory- 
lation of annexin I in vivo, as we have shown phosphorylation 
of annexin I in vitro to cause its release from MVBs in the 
presence of calcium chelator.  To confirm,  as our in vitro 
results would suggest, that the loss of calcium-independent 
annexin I  through phosphorylation occurs in MVBs rather 
than on the plasma membrane, the amount of annexin I as- 
sociated with plasma membrane fractions containing wild 
type and those containing kinase negative EGF-R was com- 
pared.  Plasma  membrane  fractions  containing  wild  type 
EGF-R and those containing  kinase negative EGF-R con- 
tained similar levels of annexin I relative to EGF-R (Fig. 7), 
suggesting that the release of calcium independent annexin 
I  through  phosphorylation does  not  occur on  the  plasma 
membrane. 
Discussion 
We have shown in previous studies that an active EGF-R ki- 
nase is necessary for lysosomal sorting  (Honegger et al., 
1987;  Felder  et  al.,  1990).  Other investigators have also 
shown a reduction in EGF-stimulated degradation of EGF in 
cells expressing a kinase negative EGF-R but they have con- 
cluded  that  this  is  due  to  a  reduced  internalization  rate, 
rather than to defective lysosomal sorting (Glenney et al., 
1988; Chen et al.,  1989; Wiley et al.,  1991).  Most recently 
Felder et al. (1992) obtained data to suggest that the role of 
the EGF-R kinase in internalization concerns primarily high 
affinity EGF-R.  At the  saturating  concentrations  of EGF 
used in the present study our previous biochemical and mor- 
phological  studies  (Felder et al.,  1990)  clearly show that 
there is a similar rate of internalization of both the wild type 
and the kinase negative EGF-R and it is in the MVB that the 
pathways of the  wild type and kinase negative EGF-R di- 
verge. A recent study of another growth factor receptor ki- 
nase, the receptor for colony stimulating factor 1, has shown 
that an active kinase is not necessary for internalization but 
is  a  requirement  for  lysosomal  sorting  (Carlberg  et  al., 
1991). 
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degradation indicates that either the EGF-R must be auto- 
phosphorylated to be efficiently targeted to lysosomes, or the 
kinase phosphorylates  a substrate necessary for lysosomal 
targeting. When kinase positive and kinase negative EGF-R 
are expressed in the same cell,  heterodimers  form in re- 
sponse to EGF and the kinase  negative EGF-R becomes 
tyrosine phosphorylated (Hunegger et al., 1990). However, 
in this system kinase negative EGF-R are still predominantly 
recycled. It is therefore likely that phosphorylation of a sub- 
strate accessible only in the MVB is necessary for degrada- 
tion.  This would require the EGF-R kinase to be active in 
the MVB. There is considerable evidence that the EGF-R ki- 
nase is active in the endosome. Autophosphorylation activity 
of  the EGF-R kinase has been demonstrated in vitro in endo- 
some fractions from A431 cells (Cohen and Fava, 1985) and 
rat fiver (Kay et al., 1986; Lal et al., 1989). We and others 
(Carpentier et al., 1987; Nesterov et al., 1990) have shown 
that EGF stimulation results in prolonged autophosphoryla- 
tion of the EGF-R, suggesting that the EGF-R kinase is still 
active after internalization in vivo. Wada et al. (1992) have 
shown that the EGF-R kinase is more highly phosphorylated 
in the endosome than on the plasma membrane.  Moreover 
the internalized EGF-R kinase can phosphorylate a synthetic 
substrate introduced  into permeabillzed  cells (Nesterov et 
al., 1990). 
In this study we searched for substrates of the EGF-R ki- 
nase  associated  with  MVBs.  Western  blotting  isolated 
MVBs with anti-phosphotyrosine antibody failed to reveal 
any major substrates of the EGF-R kinase apart from the 
EGF-R itself.  However, when highly purified MVBs con- 
taining the wild type EGF-R are incubated with [y-32p]ATP 
the major proteins phosphorylated are the EGF-R itself and 
annexin I.  Neither  proteins  are phosphorylated  in MVBs 
containing  the  kinase  negative  EGF-R.  Similarly  when 
MVBs  from H.Ep.2  cells  are  isolated  using  transferrin 
receptor gold in the presence or absence of EGF, only in en- 
dosomes isolated from cells that have been stimulated with 
EGF does annexin I become phosphorylated.  In contrast, 
annexin I is not phosphorylated in plasma membrane frac- 
tions whether or not an active EGF-R kinase is present. We 
have demonstrated therefore that in the presence of  an active 
EGF-R kinase annexin I can be phosphorylated  in MVBs, 
but not plasma membrane, in vitro. It is likely that annexin 
I is phosphorylated directly  by the EGF-R kinase, rather than 
through activation of an intermediate kinase, as annexin I is 
efficiently phosphorylated by purified EGF-R kinase (De et 
al., 1986; Huang et al., 1986) and there is no evidence of 
an intermediate substrate in the MVB preparations. 
Our in vitro results  are consistent  with the kinetics  of 
phosphorylation  of annexin I in vivo.  Sawyer and Cohen 
(1985) showed that annexin I is not phosphorylated until the 
majority of  EGF-R have been internalized and suggested that 
annexin is phosphorylated by the endosomal EGF-R kinase. 
Cohen and Fava (1985) showed that purified annexin I added 
to a partially purified intracellular vesicle fraction could be 
phosphorylated by the EGF-R kinase, and that this reaction 
was dependent upon the presence of calcium. In the present 
study we show an association of endogenous aunexin I with 
endosomes that is independent of calcium but this form of 
annexin I can be phosphorylated by the EGF-R kinase and 
upon phosphorylation  requires  calcium for membrane  as- 
sociation. This is in agreement with the studies of Haigler 
et  al.  (1987) who  showed  that  phosphorylation  of the 
calcium-independent form of armexin I in human placental 
membranes converts it into a form that requires calcium for 
membrane association. The nature of the calcium-indepen- 
dent interaction of  annexin I with membranes is unknown but 
we have shown here that the association is independent of  the 
density  of EGF-R  within the membrane.  The interaction 
therefore presumably  does not involve a direct interaction 
with the EGF-R such has been described for the EGF-R ki- 
nase  substrates,  Phospholipase  C y  (Miesenhelder  et al., 
1989), GAP (Bouton et al., 1991), Raf-1 (App et al., 1991), 
and Vav (Bustelo et al., 1992; Margolis et al., 1992) which 
interact with EGF-R via SH2 domains. Quantitation of the 
total amount of annexin I in plasma membrane  and MVB 
fractions has shown that the presence or absence of  an active 
EGF-R kinase has little effect on the amount of annexin I in 
plasma  membrane  fractions  but the presence  of an active 
EGF-R kinase causes a reduction in the amount of annexin 
I in MVB fractions.  These results are consistent with an- 
nexin I being phosphorylated in MVBs and thus converted 
to a form that is eluted during fractionation in the presence 
of calcium chelator. 
Wada et al.  (1992) in  a  study  of phosphoproteins  as- 
sociated with endosomes of rat liver did not report annexin 
I associated with endosomes. Wada  et al. (1992) did however 
detect a 55-kD phosphoprotein associated with endosomes. 
We were not able to detect this substrate in either NIH 3T3 
or H.Ep.2 cells, either after in vitro phosphorylation or by 
Western blotting isolated fractions with anti-phosphotyro- 
sine  antibody  (results not shown). These differences may 
arise because different stages of processing of the EGF-R 
were examined. Wada et al. (1992) studied endosomes iso- 
lated a maximum of 15 rain after EGF stimulation. At this 
time point the authors were unable to demonstrate sequestra- 
tion of  EGF-R within intra-luminal vesicles in the liver. That 
sequestration of  EGF-R in intra-luminal vesicles does occur 
in the liver has been shown by Renfew and Hubbard (1992). 
In agreement with our proposal the latter authors suggest that 
movement of EGF-R from the limiting membrane of endo- 
somes to the lumen of lysosomes permits degradation of the 
EGF-R. Wada et al.  (1992) may thus have been examining 
early events in the processing of the EGF-R, before removal 
of EGF-R from the limiting membrane. 
Thus  we have shown that annexin I  is associated  with 
plasma  membrane and  MVBs  in  a  calcium-independent 
manner and can be phosphorylated in vitro in the presence 
of  an active EGF-R kinase in MVBs, but not in plasma mem- 
brane. Phosphoryladon of the calcium-independent form of 
annexin I converts it into a form that requires calcium for 
membrane association.  MVBs, but not plasma membrane, 
containing an active EGF-R kinase  contain less  calcium- 
independent annexin I than those that do not contain an ac- 
tive  EGF~R kinase.  We  believe  therefore  that  calcium- 
independent annexin I is phosphorylated  in vivo in MVBs 
whereupon it is released during fractionation in the presence 
of calcium chelator. 
The requirement  for the EGF-R kinase to be active for 
transfer to the inner vesicles of MVBs (Felder et al., 1990), 
together with the demonstration here that annexin I is a ma- 
jor phosphorylated substrate in MVBs, suggest that annexin 
I may play a role in mediating inward vesiculation.  Mere- 
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process at other membrane boundaries but it is important to 
note that in these situations the evaginating face of the mem- 
brane is cytoplasmic. In contrast, during inward vesiculation 
in MVBs the evaginating face of the membrane is luminal. 
Annexin I has been shown to mediate vesicle aggregation and 
a model has been proposed whereby annexin molecules bind 
to phospholipid vesicles  and  fusion between  neighboring 
membranes is mediated by interaction of annexin molecules 
(Blackwood  and  Ernst,  1990;  Ernst et al.,  1991).  In the 
MVB interaction of neighbouring molecules of annexin I on 
the perimeter membrane may have a role in driving inward 
vesiculation. Release of annexin I through phosphorylation 
may then be required for the inward release of vesicles from 
the perimeter  membrane.  Subfractionation  of the MVB to 
analyse the protein composition of the perimeter membrane 
and inner vesicles and the development of in vitro systems 
to study inward vesiculation may allow the molecular dissec- 
tion of the events leading to the formation of internal vesicles 
in the MVB. 
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